Integrated Department of Immunology, National Jewish Health, Denver, CO 80206, USA.
Curr Opin Immunol. 2013 Dec;25(6):775-80. doi: 10.1016/j.coi.2013.07.012. Epub 2013 Aug 23.
Chronic beryllium disease (CBD) is a granulomatous lung disorder caused by a hypersensitivity to beryllium and characterized by the accumulation of beryllium-specific CD4(+) T cells in the lung. Genetic susceptibility to beryllium-induced disease is strongly associated with HLA-DP alleles possessing a glutamic acid at the 69th position of the β-chain (βGlu69). The structure of HLA-DP2, the most prevalent βGlu69-containing molecule, revealed a unique solvent-exposed acidic pocket that includes βGlu69 and represents the putative beryllium-binding site. The delineation of mimotopes and endogenous self-peptides that complete the αβTCR ligand for beryllium-specific CD4(+) T cells suggests a unique role of these peptides in metal ion coordination and the generation of altered self-peptides, blurring the distinction between hypersensitivity and autoimmunity.
慢性铍病(CBD)是一种由铍过敏引起的肉芽肿性肺部疾病,其特征是铍特异性 CD4(+)T 细胞在肺部积聚。对铍诱导疾病的遗传易感性与 HLA-DP 等位基因强烈相关,该基因具有β链第 69 位的谷氨酸(βGlu69)。HLA-DP2 的结构揭示了一个独特的溶剂暴露酸性口袋,其中包括βGlu69,代表潜在的铍结合位点。模拟表位和内源性自身肽的描绘完成了铍特异性 CD4(+)T 细胞的 αβTCR 配体,这表明这些肽在金属离子配位和产生改变的自身肽方面具有独特的作用,从而模糊了超敏反应和自身免疫之间的区别。